The triple-negative breast cancer (TNBC) subtype, which is negative for the progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor 2 receptor expression (HER2), accounts for approximately 10% of all the breast cancers [2]. This evidence concerns the gene ERBB2 and breast carcinoma.